Trusopt and Respiratory disorder - a phase IV clinical study of FDA data

Summary:

Respiratory disorder is reported as a side effect among people who take Trusopt (dorzolamide hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Cortef, and have Metastases to central nervous system.

The phase IV clinical study analyzes which people have Respiratory disorder when taking Trusopt. It is created by eHealthMe based on reports of 3,123 people who have side effects when taking Trusopt from the FDA, and is updated regularly.

What is Trusopt?

Trusopt has active ingredients of dorzolamide hydrochloride. It is often used in glaucoma. eHealthMe is studying from 3,165 Trusopt users. Check the latest studies of Trusopt.

What is Respiratory disorder?

Respiratory disorder (respiratory disease) is found to be associated with 1,539 drugs and 1,583 conditions by eHealthMe. Check the latest studies of Respiratory disorder.

On Aug, 04, 2026

3,123 people reported to have side effects when taking Trusopt.
Among them, 15 people (0.48%) have Respiratory disorder.

Could Trusopt cause Respiratory disorder?

Among these 15 people:

How long have people been on Trusopt when they have Respiratory disorder? *

What is the gender of people who have Respiratory disorder when taking Trusopt? *

female: 23.08 %
male: 76.92 %

What is the age of people who have Respiratory disorder when taking Trusopt? *

What are other drugs people take besides Trusopt? *

What are other side effects people have besides Respiratory disorder? *

Aortic Valve Incompetence: 8 people, 53.33%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 8 people, 53.33%
Haematoma (collection of blood outside the blood vessels): 7 people, 46.67%
Depression: 7 people, 46.67%
Injury: 7 people, 46.67%
Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 46.67%
Hearing Impaired: 7 people, 46.67%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 7 people, 46.67%
Fall: 7 people, 46.67%
Dyspnea (difficult or laboured breathing): 7 people, 46.67%

What are the existing conditions these people have? *

Stress And Anxiety: 7 people, 46.67%
Metastases To Central Nervous System (cancer spreads to central nervous system): 7 people, 46.67%
Type 2 Diabetes: 1 person, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.67%
Blood Testosterone Decreased: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Trusopt and have Respiratory disorder?

- Check whether Respiratory disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trusopt:

Trusopt (3,165 reports)

Browse all side effects of Trusopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory disorder:

Respiratory disorder (1,539 drugs)

Browse all the conditions that are associated with Respiratory disorder:

Respiratory disorder (1,583 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dorzolamide hydrochloride (the active ingredients of Trusopt) and Trusopt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.